Ajay Padmanaban

Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia

Lene Russell, Kis Rønn Uhre, Ann Louise Syraach Lindgaard et al. · JAMA · 2021 · 263 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +13

Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial

Anders Granholm, Marie Warrer Munch, Sheila Nainan Myatra et al. · Intensive Care Medicine · 2021 · 122 citations · Full text

Public Health, Pharmacology, Pharmacotherapy +17

Long-term outcomes of dexamethasone 12 mg versus 6 mg in patients with COVID-19 and severe hypoxaemia

Anders Granholm, Maj-Brit N. Kjær, Marie Warrer Munch et al. · Intensive Care Medicine · 2022 · 31 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +12

Higher vs lower doses of dexamethasone in patients with COVID‐19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis plan

Anders Granholm, Maria Cronhjort, RR Wahlin et al. · Acta Anaesthesiologica Scandinavica · 2021 · 27 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +17

Feasibility and Safety of Peripheral Intravenous Administration of Vasopressor Agents in Resource-limited Settings

Ajay Padmanaban, Ramesh Venkataraman, Senthilkumar Rajagopal et al. · ˜The œJournal of Critical Care Medicine · 2020 · 16 citations · Full text

Nursing, Internal Medicine, Pharmacotherapy +17